These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
43 related items for PubMed ID: 11237406
1. Thy-1 associated pp85--90 is a potential docking site for SH2 domain-containing signal transduction molecules. Durrheim GA, Garnett D, Dennehy KM, Beyers AD. Cell Biol Int; 2001; 25(1):33-42. PubMed ID: 11237406 [Abstract] [Full Text] [Related]
2. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains. Chalupny NJ, Aruffo A, Esselstyn JM, Chan PY, Bajorath J, Blake J, Gilliland LK, Ledbetter JA, Tepper MA. Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101 [Abstract] [Full Text] [Related]
3. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases. Susa M, Rohner D, Bichsel S. Biochem Biophys Res Commun; 1996 Mar 27; 220(3):729-34. PubMed ID: 8607833 [Abstract] [Full Text] [Related]
4. Regulation of Lck and Fyn tyrosine kinase activities by transmembrane protein tyrosine phosphatase leukocyte common antigen-related molecule. Tsujikawa K, Ichijo T, Moriyama K, Tadotsu N, Sakamoto K, Sakane N, Fukada S, Furukawa T, Saito H, Yamamoto H. Mol Cancer Res; 2002 Dec 27; 1(2):155-63. PubMed ID: 12496362 [Abstract] [Full Text] [Related]
6. Tyrosine-614, the major autophosphorylation site of the receptor tyrosine kinase HEK2, functions as multi-docking site for SH2-domain mediated interactions. Hock B, Böhme B, Karn T, Feller S, Rübsamen-Waigmann H, Strebhardt K. Oncogene; 1998 Jul 16; 17(2):255-60. PubMed ID: 9674711 [Abstract] [Full Text] [Related]
11. Molecular alterations of the Fyn-complex occur as late events of human T cell activation. Marie-Cardine A, Kirchgessner H, Schraven B. Eur J Immunol; 1999 Apr 16; 29(4):1175-87. PubMed ID: 10229084 [Abstract] [Full Text] [Related]
12. Interactions between the Fyn SH3-domain and adaptor protein Cbp/PAG derived ligands, effects on kinase activity and affinity. Solheim SA, Petsalaki E, Stokka AJ, Russell RB, Taskén K, Berge T. FEBS J; 2008 Oct 16; 275(19):4863-74. PubMed ID: 18721137 [Abstract] [Full Text] [Related]
13. Association of p59(fyn) with the T lymphocyte costimulatory receptor CD2. Binding of the Fyn Src homology (SH) 3 domain is regulated by the Fyn SH2 domain. Lin H, Hutchcroft JE, Andoniou CE, Kamoun M, Band H, Bierer BE. J Biol Chem; 1998 Jul 31; 273(31):19914-21. PubMed ID: 9677430 [Abstract] [Full Text] [Related]
14. The effect of transient global ischemia on the interaction of Src and Fyn with the N-methyl-D-aspartate receptor and postsynaptic densities: possible involvement of Src homology 2 domains. Takagi N, Cheung HH, Bissoon N, Teves L, Wallace MC, Gurd JW. J Cereb Blood Flow Metab; 1999 Aug 31; 19(8):880-8. PubMed ID: 10458595 [Abstract] [Full Text] [Related]
16. Binding, domain orientation, and dynamics of the Lck SH3-SH2 domain pair and comparison with other Src-family kinases. Hofmann G, Schweimer K, Kiessling A, Hofinger E, Bauer F, Hoffmann S, Rösch P, Campbell ID, Werner JM, Sticht H. Biochemistry; 2005 Oct 04; 44(39):13043-50. PubMed ID: 16185072 [Abstract] [Full Text] [Related]
18. Physical and functional interactions of protein tyrosine kinases, p59fyn and ZAP-70, in T cell signaling. Fusaki N, Matsuda S, Nishizumi H, Umemori H, Yamamoto T. J Immunol; 1996 Feb 15; 156(4):1369-77. PubMed ID: 8568236 [Abstract] [Full Text] [Related]
19. Distinct binding patterns of HS1 to the Src SH2 and SH3 domains reflect possible mechanisms of recruitment and activation of downstream molecules. Takemoto Y, Sato M, Furuta M, Hashimoto Y. Int Immunol; 1996 Nov 15; 8(11):1699-705. PubMed ID: 8943564 [Abstract] [Full Text] [Related]
20. The association of the protein tyrosine kinases p56lck and p60fyn with the glycosyl phosphatidylinositol-anchored proteins Thy-1 and CD48 in rat thymocytes is dependent on the state of cellular activation. Garnett D, Barclay AN, Carmo AM, Beyers AD. Eur J Immunol; 1993 Oct 15; 23(10):2540-4. PubMed ID: 8104794 [Abstract] [Full Text] [Related] Page: [Next] [New Search]